JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A3011 CHIR-99021 (CT99021)
2 Citation

Target: GSK-3

Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive

≥23.27 mg/mL
B5614 Cardionogen 1

Summary: Wnt signaling modulator

<5.49 mg/mL
B5979 CCT251545

Summary: Orally bioavailable and potent WNT signaling inhibitor

≥42.2 mg/mL
B2306 IWR-1-endo
1 Citation

Summary: Potent Wnt signaling inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.45 mg/mL
A8217 ICG 001
1 Citation

Summary: Wnt/β-catenin pathway inhibitor

≥27.43 mg/mL
A1877 XAV-939
1 Citation

Target: TNKS

Summary: Tankyrase 1/2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
A8396 CHIR-99021 (CT99021) HCl

Target: GSK-3

Summary: GSK-3α/β inhibitor

≥25.1 mg/mL
A8601 Tankyrase Inhibitors (TNKS) 49

Target: Tankyrases

Summary: Tankyrase inhibitor

≥22.45 mg/mL
A8685 Wnt-C59
2 Citation

Target: PORCN

Summary: PORCN inhibitor,highly potent and selective

.95 mg/mL

insoluble in H2O; ≥18
B2307 LGK-974
1 Citation

Summary: PORCN inhibitor,potent and specific

insoluble in H2O; ≥19.8 mg/mL